Navigation Links
Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
Date:4/23/2008

armaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA immunotherapeutics for cancer, in which the expressed protein is an immune system stimulant; DNA vaccines for infectious diseases, in which the expressed protein is an immunogen; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and serve significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether Vical or others will continue development of Allovectin-7(R); whether Vical will be able to recruit patients into the AIMM trial as planned, if at all; whether the results from the Phase 2 trial or those reflected in the video report are indicative of results in any future testing of Allovectin-7(R); whether Vical will receive all of the clinical trial funding from AnGes under the collaborative agreement, which will depend on continued development of Allovectin-7(R) and certain other conditions, as well as AnGes' compliance with its contractual obligations under the agreement; whether Vical or others will evaluate potential additional applications of the company's technology; whether Allovectin-7(R) or any other product candidates will be shown to be saf
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
8. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored at ... Technology in the Service of Society Award. IEEE President and ... Barry L. Shoop presented the award to Principal Scientist ... ceremony was held Saturday, June 20, 2015, at the historic ... . "I have spent more than 3 ...
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... Nev. , June 29, 2015  PDL BioPharma, ... has entered into a credit agreement with CareView Communications, ... up to $40 million of secured debt financing. CareView ... focused on patient care monitoring. Under the ... $40 million of debt financing in two tranches of ...
Breaking Medicine Technology:Daktari Honored with IEEE Spectrum Award 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4
... Oct. 24, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... & Drug Administration (FDA) has scheduled a meeting of ... 2011, at which the ADASUVE New Drug Application (NDA) ... that the FDA had accepted the resubmission of the ...
... 2011 Covance Inc. (NYSE: CVD ) ... Shanghai, China, has received Good Laboratory Practice (GLP) certification ... the Organization for Economic Cooperation and Development (OECD). The ... toxicology, in-vivo PK screening, and metabolism services. ...
Cached Medicine Technology:Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011 2Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011 3Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China 2
(Date:6/29/2015)... NEW YORK (PRWEB) , ... June 29, 2015 ... ... apnea (OSA) is now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The device ... Administration and is an alternative to continuous positive airway pressure (CPAP), the current ...
(Date:6/29/2015)... ... June 29, 2015 , ... Human Factors ... Webinar**, July 16, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/humanfactors ... human factors engineering to the design of new products as well as to ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... developed a new approach to build nearly complete genomes by combining high-throughput DNA ... genomic variation, critically important for their association with human disease, but previously difficult ...
(Date:6/29/2015)... OH (PRWEB) , ... June 29, 2015 , ... ... support to healthcare providers for patients with certain neuropsychiatric and chronic pain conditions, ... President and CEO. , The appointments include: Peter Donato, Senior Vice President, Chief ...
(Date:6/29/2015)... ... June 29, 2015 , ... OR Manager announced Monday the launch of an ... well as a redesigned logo and weekly eLetter. The website contains the same informational ... and easier to navigate. , In addition to a refreshed look, http://www.ormanager.com ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:OR Manager Launches New Website 2
... By Jenifer Goodwin HealthDay Reporter , ... a good predictor of academic performance, but not necessarily ... tested the IQs and reading, spelling and math abilities ... the children,s social functioning through parental and teacher reports ...
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) ... the year, many Americans will soon be subjected to radiation-emitting ... tide of concerns and complaints in recent weeks over body ... is too low to pose any serious health threat. ...
... 2010) - Even though most people are aware that good ... mother and child, misunderstandings about the safety of dental care ... dentist. The fact is that dentists can create a treatment ... adverse effects of oral disease during pregnancy. During the ...
... Reporter , TUESDAY, Nov. 23 (HealthDay News) -- Being born just ... child,s IQ and ability to pay attention, new research suggests. ... to those born between 34 to 36 weeks (called "late ... twice the risk of having an IQ score below 85 and ...
... HealthDay Reporter , MONDAY, Nov. 22 (HealthDay ... antioxidant cousin, alpha-carotene, in fruits and vegetables can lower ... disease and cancer, new research suggests. Both ... because of the red, yellow and orange coloring they ...
... , TUESDAY, Nov. 23 (HealthDay News) ... and efficiency while preventing sudden death among heart ... survival in real-world situations as they are in ... finding is based on an analysis of nearly ...
Cached Medicine News:Health News:For Autistic Kids, IQ May Not Predict School Achievement 2Health News:For Autistic Kids, IQ May Not Predict School Achievement 3Health News:Airport Body Scanners Safe, Experts Say 2Health News:Airport Body Scanners Safe, Experts Say 3Health News:Expecting? Don't neglect your teeth 2Health News: Children Born 'Late Pre-Term' More Prone to Low IQ 2Health News: Children Born 'Late Pre-Term' More Prone to Low IQ 3Health News:Eat Your Fruits & Veggies for Longer Life 2Health News:Eat Your Fruits & Veggies for Longer Life 3Health News: Implanted Heart Devices Have 'Real-World' Benefits: Study 2Health News: Implanted Heart Devices Have 'Real-World' Benefits: Study 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: